Q1 2019 Eli Lilly and Co Earnings Call Transcript

Apr 30, 2019 / 01:00PM GMT
Operator

Thank you, ladies and gentlemen, for standing by. Welcome to the Q1 2019 earnings call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to our VP of Investor Relations, Kevin Hern. Please go ahead.

Kevin Hern - Eli Lilly and Company - VP of IR

Thank you. Good morning. Thank you for joining us for Eli Lilly and Company's Q1 2019 Earnings Call. I'm Kevin Hern, Vice President of Investor Relations. Joining me on today's call are: Dave Ricks, Lilly's Chairman and CEO; Josh Smiley, our Chief Financial Officer; Dr. Dan Skovronsky, President of Lilly Research Laboratories; Christi Shaw, President of Lilly Bio-Medicines; Anne White, President of Lilly Oncology; and Enrique Conterno, President of Lilly Diabetes and Lilly U.S.A. We're also joined by Kim Macko and Mike Czapar of the Investor Relations team.

During this conference call, we anticipate making projections and forward-looking statements based on our current expectations. Our actual results could differ materially due to a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot